Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What generation is ceftriaxone?Alphagan generic name?Accutane 30 mg price?De10021667 acarbose us patent?Clonidine hydrochloride discount?
See the DrugPatentWatch profile for Movantik
Movantik (naloxegol) uses naloxegol, a peripherally acting mu-opioid receptor antagonist. It is designed to counteract opioid effects in the gut (bowel) without blocking pain relief in the brain.
Movantik uses naloxegol to block opioid receptors in the gastrointestinal tract, which can reduce constipation caused by opioids.
The active ingredient in Movantik is naloxegol.
If you’re looking for patent or exclusivity details for Movantik (naloxegol), DrugPatentWatch.com tracks those filings and timelines: https://www.drugpatentwatch.com/
Other Questions About Movantik :